Corneal allergy complications in children can even lower their parents’ quality of life.
Schools and day care centers should implement allergy training and action plans and have unassigned epinephrine autoinjectors for use, but site-wide food prohibitions are not suggested for allergy management.
A study supports the use of a calcineurin inhibitor for severe ocular allergies.
Higher conjunctivitis prevalence seen among allergic rhinitis patients than nonallergic.
Researchers saw a general trend of superior efficacy with the treatment.
Previously unrecognized pathogenic mechanisms involving ocular contact dermatitis has driven new approaches to control the inflammatory process.
The investigation found ocular complications are the most commonly reported adverse event associated with treatment, especially in patients with asthma.
A study shows these patients have a higher likelihood of visual impairment, eye disorders, and glaucoma.
Researchers detail case reports of 20 patients and examine a potential association between a treatment for facial eczema and conjunctivitis.
Report reviews the utility of allergy-specific immunotherapy in allergic rhinoconjunctivitis.
Research concludes that mast cells are a potential therapeutic target in corneal neovascularization treatment.
Researchers compare allergic responses, including conjunctivitis, from various allergens.
Telemedicine offers new possibilities in the diagnosis and follow-up care of ocular surface diseases.
A study reviews the neonatal outcomes of exposure to ophthalmic corticosteroids.
The medication improved both ocular and nasal allergy symptoms.
Investigators identify the advantages and disadvantages of questionnaires designed to quantify the impact of different etiologies of ocular allergy.
Researchers show how aggNET-limiting therapies can manage meibomian gland dysfunction.
Researchers analyzed real-world evidence on the safety and efficacy of dupilumab to treat atopic dermatitis.
Ragweed sublingual immunotherapy tablet improved symptoms and decreased the need for rescue medication in the largest allergy immunotherapy trial in children with ragweed allergic rhinitis with or without conjunctivitis.
Diclofenac sodium topical gel and olopatadine HCl ophthalmic drops will soon be available over-the-counter (OTC) after the the Food and Drug Administration (FDA) switched the status of these products from prescription to nonprescription.